NMDA Receptor
NMDA (N-methyl-D-aspartate) receptor is a glutamate-gated cation channels that plays a vital role in regulating synaptic transmission, neuroplasticity and central nervous system development. It is involved in a range of physiological processes such as learning, memory and pain etc.
Products Related to NMDA Receptor(77)
- GC14547Quinolinic acidCAS: 89-00-9Purity: >99.00%
Quinolinic acid, a neuroactive metabolite of the kynurenine pathway, is an endogenous neurotoxin.
- GC16240MNI-caged-NMDACAS: 1227675-52-6Purity: >98%
NMDA caged with the photosensitive 4-methoxy-7-nitroindolinyl group
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC14381 | Ro 8-4304 hydrochloride | 1312991-77-7 | >98% | |
NMDA receptor antagonist | ||||
| GC14414 | CIQ | 486427-17-2 | >98.00% | |
NMDA receptor potentiator | ||||
| GC14442 | TCS 46b | 302799-86-6 | >98% | |
NR1A/NR2B NMDA receptor antagonist,orally active | ||||
| GC14470 | Arcaine sulfate | 14923-17-2 | >95.00% | |
NMDA antagonist | ||||
| GC14547 | Quinolinic acid | 89-00-9 | >99.00% | |
Quinolinic acid, a neuroactive metabolite of the kynurenine pathway, is an endogenous neurotoxin. | ||||
| GC14598 | 5,7-Dichlorokynurenic acid sodium salt | 1184986-70-6 | >98% | |
NMDA receptor antagonist | ||||
| GC14770 | TCN 213 | 556803-08-8 | >98% | |
NR1/NR2A selective NMDA receptor antagonist | ||||
| GC14782 | Ro 04-5595 hydrochloride | 64047-73-0 | >98% | |
NR2B-containing NMDA receptors antagonist | ||||
| GC14810 | L-701,324 | 142326-59-8 | >99.50% | |
NMDA receptor antagonist | ||||
| GC14897 | DL-AP5 Sodium salt | 1303993-72-7 | >98% | |
NMDA receptor antagonist | ||||
| GC15065 | TCN 201 | 852918-02-6 | >98.50% | |
NR1/NR2A selective NMDA receptor antagonist | ||||
| GC15112 | D-AP7 | 81338-23-0 | >98% | |
NMDA receptor antagonist | ||||
| GC15156 | Conantokin-T | 127476-26-0 | >98% | |
Non-competitive NMDA receptor antagonist | ||||
| GC15343 | Eliprodil | 119431-25-3 | >98.50% | |
NMDA receptor antagonist | ||||
| GC15732 | Synthalin sulfate | 182285-12-7 | >98% | |
NMDA receptor antagonist | ||||
| GC15752 | CGP 78608 hydrochloride | 206648-13-7 | >98% | |
NMDA antagonist | ||||
| GC16131 | Remacemide hydrochloride | 111686-79-4 | >98% | |
NMDA receptor antagonist | ||||
| GC16240 | MNI-caged-NMDA | 1227675-52-6 | >98% | |
NMDA caged with the photosensitive 4-methoxy-7-nitroindolinyl group | ||||
| GC16272 | CGS 19755 | 110347-85-8 | >98.00% | |
NMDA receptor antagonist | ||||
| GC16315 | D-AP5 | 79055-68-8 | >98.00% | |
D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist with a K d value of 1.4μM. | ||||
| GC16616 | (+)-MK 801 | 70449-94-4 | >98.00% | |
| GC16776 | QNZ 46 | 1237744-13-6 | >98.00% | |
NR2C/NR2D-selective NMDA receptor antagonist | ||||
| GC16799 | 5,7-Dichlorokynurenic acid | 131123-76-7 | >98% | |
NMDA receptor antagonist | ||||
| GC16915 | (2R,3S)-Chlorpheg | 140924-23-8 | >98% | |
NMDA receptor antagonist | ||||